HER2-targeted Therapy for Salivary Gland Cancer
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
A poster at the AACR Annual Meeting 2024 examined a video that increased awareness of prostate cancer.
Experts discussed "Discovery Science in Early Cancer Biology and Interception" at a plenary during the AACR Annual Meeting 2024.
The 2024 AACR June L. Biedler Prize for Cancer Journalism winners were honored during the AACR Annual Meeting 2024.
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The AACR Annual Meeting 2024 Opening Ceremony showcased impactful initiatives impacting cancer research.
A special issue of Cancer Discovery illustrates the vast landscape of research being explored within the AACR community.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
AACRoC in Brazil let young investigators learn from cancer research experts during programs in São Paulo and Ribeirão Preto.